Principal Investigator (PI)
Christianne Roumie, MD, MPH
Professor, Internal Medicine & Pediatrics
Deputy Director, VA TVHS Quality Scholars Program
Director, Master of Public Health Program, Vanderbilt University
Dr. Roumie is the Program Director of the MPH program at Vanderbilt and the Deputy Director of the VA Quality Scholars Program at Nashville. She is a standing member of the Food and Drug Administration's Nonprescription Drugs Advisory Committee and serves as chairwoman. Dr. Roumie's research portfolio evaluates appropriate medication utilization as a barrier to optimal patient outcomes and as risk factors for cardiovascular disease. Additionally, her research programs on comparative effectiveness research explore ways to improve health outcomes by developing evidence-based information for patients, clinicians, and decision-makers about the most effective interventions for patients. Dr. Roumie has participated in multiple expert committees on appropriate medication prescribing including: Agency for Healthcare Research and Quality Diabetes Multi-Center Research Consortium Executive Committee, the Veterans Health Administration Geriatrics Pharmacy taskforce on appropriate prescribing, and serves as a member of the Food and Drug Administration's Nonprescription Drugs Advisory Committee (NDAC). She serves as Principal Investigator of the Learning Health System Scholars (LHS K12) and the Patient/pRactice Outcomes Research in Effectiveness and Systems Science (PROgRESS) T32 Programs. Dr. Roumie is Program Director of The Vanderbilt Scholars in T4 Translational Research (V-STTaR) K12 Program.
Program Director (PD)
Russell Rothman, MD, MPP
Professor, Internal Medicine, Pediatrics & Health Policy
Ingram Chair in Integrative and Population Health
Senior Vice President, Population and Public Health
Director, Institute for Medicine and Public Health
Dr. Rothman is a Professor of Internal Medicine, Pediatrics, and Health Policy. He serves as Senior Vice President for Population Health Research at Vanderbilt University Medical Center, and he is Chief of the Internal Medicine and Pediatrics Section in the Department of Medicine. As Director of the Institute for Medicine and Public Health, Dr. Rothman oversees an Institute that engages more than 292 faculty members involved in health services research, implementation science, behavioral research, health disparities research, quality improvement research and other areas aimed at improving health outcomes. He currently serves as the Principal Investigator of the PCORI funded STAR Clinical Research Network, which engages Vanderbilt University Medical Center, the Vanderbilt Health Affiliated Network, Meharry Medical College, Duke, UNC, Wake Forest, Health Sciences of South Carolina and Mayo. The network includes electronic health record data on over 12 million patients and supports pragmatic clinical research and real world evidence research. Dr. Rothman also led the CMS funded Mid-South Practice Transformation Network, which engaged over 4,000 clinicians in quality improvement in the Mid-South region. His current research focuses on preventing, managing, and improving care for adult and pediatric patients with chronic diseases, with particular focus on health literacy and numeracy in patients with diabetes and obesity.
Executive Committee
Carlos G. Grijalva, MD, MPH
Professor, Division of Pharmacoepidemiology, Department of Health Policy
Co-Director, Vanderbilt's Developing Evidence to Inform Decisions about Effectiveness (DEcIDE)
Dr. Grijalva is a member of the Vanderbilt Epidemiology Center, a Scholar at the Vanderbilt Center for Health Services Research, and an investigator at the Veterans Affairs Tennessee Valley Geriatric Research Education and Clinical Center. His interests include the evaluation of medications’ safety and effectiveness; the design of observational studies; and, methodologies for comparative effectiveness research. Dr. Grijalva is experienced designing and conducting studies of medications effects using large databases, and his research focuses on the assessments of medications used for diabetes, opioid analgesics, biologic medications, vaccine-preventable respiratory diseases - especially pneumococcal and influenza infections - and the evaluation of the effectiveness of vaccination and other preventive programs.
Sunil Kripalani, MD, MSc, SFHM, FACP
Professor of Medicine
Director, Center for Clinical Quality and Implementation Research
Director, Center for Health Services Research
Dr. Kripalani is the founding Director of the Center for Clinical Quality and Implementation Research and the Director of the Center for Health Services Research. He has developed, implemented, and evaluated numerous interventions to improve the quality, safety, value, and patient-centeredness of health care delivery, with a focus on health communication, social determinants of health, medication management, and transitions of care. He has experience in the development of evidence-based toolkits, mentored implementation programs, mixed-methods evaluation of interventions in clinical practice, and de-implementation of wasteful practices.
Todd Rice, MD, MSCI
Associate Professor of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine
Vice President for Clinical Trial Innovation and Operation in the Vanderbilt Institute of Clinical and Translational Science
Dr. Rice is a member of the American Thoracic Society, American College of Chest Physicians, and the Society of Critical Care Medicine. He is also an investigator in the National Institutes of Health ARDS Network. His research interests include sepsis, critical care nutrition, and acute lung injury, resulting in more than 30 publications and book chapters. He has an NIH-funded K23 mentored career-development grant investigating the effects of target enteral feeding on inflammation in patients with respiratory failure. Dr. Rice has delivered National and International lectures in critical care nutrition and acute lung injury. He currently serves as the Associate Director of the Vanderbilt medical ICU.
Christopher Lindsell, PhD
Professor of Biostatistics
Director, VICTR Methods Program
CO-Director, HEAlth Data Science Center
Dr. Lindsell has dedicated his career to collaborative biostatistics, research design, and clinical research operations. His research interests target the acute care environment with emphasis on the role of emergency medicine in improving health and healthcare at the individual and population level, and on risk stratification, medical decision making and biomarker development. He is nationally recognized for building clinical research infrastructure and for designing and implementing clinical research in the prehospital and acute care settings. He has published over 240 peer-reviewed manuscripts, holds several patents, and has served as the PI or the principal biostatistician on numerous single and multi-center clinical trials, epidemiological studies and health services research programs.
Thomas R. Talbot, MD, MPH, FSHEA, FIDSA
Professor of Medicine
Chief Hospital Epidemiologist
Dr. Talbot is a Professor of Medicine and Health Policy at Vanderbilt University School of Medicine. He also serves as the Chief Hospital Epidemiologist for Vanderbilt University Medical Center. Dr. Talbot is a recognized expert in the field of healthcare epidemiology and infection control, as he currently serves as a member of the Centers for Disease Control and Prevention’s Healthcare Infection Control Practices Advisory Committee (HICPAC) and recently served on the Board of Directors for the Society for Healthcare Epidemiology of America (SHEA). As a part of his role as the Chief Hospital Epidemiologist, he oversees the surveillance of hospital-acquired infections, the development of education for staff and physicians, and the implementation of various quality improvement interventions designed to reduce the incidence of hospital-acquired infections at Vanderbilt.
Stakeholder Advisory Committee
Robert Dittus, MD, MPH (Chair)
Albert and Bernard Werthan Chair and Professor in Medicine
Executive Vice President, Public Health and Healthcare
Chief Innovation Officer and Senior Vice President, Vanderbilt Health Affiliated Network
Gordon Bernard, MD
PI, Clinical and Translational Science Award
Professor of Medicine
Melinda Owen Bass Professor of Medicine
Consuelo Wilkins, MD, MSCI
Professor of Medicine
Vice President for Health Equity
PI, Vanderbilt CTSA
Executive Director, Meharry Vanderbilt Alliance
Kevin Johnson, MD, MS, FAAP, FACMI
Cornelius Vanderbilt Professor and Chair of Biomedical Informatics
Professor of Pediatrics
Informatician-in-Chief
Katherine Hartmann, MD, PhD
Professor of Obstetrics and Gynecology
Professor of Medicine
Associate Dean for Clinical and Translational Scientist Development
Lucius E. Burch Chair of Reproductive Physiology and Family Planning
Deputy Director, Institute for Medicine and Public Health
David Penson, MD, MPH, MMHC
Hamilton and Howd Chair, Urologic Oncology
Chair, Department of Urologic Surgery
Professor, Urologic Surgery, Medicine and Health Policy
Director, Center for Surgical Quality and Outcomes Research
Patrick Luther
Chief Program Officer Nashville Cares
Vanderbilt CTSA Community Engaged Research Core- Learning Health System Committee
Neely Williams, MDiv
Community Partners' Network: (Administrator & CEO)
Independent Consultant: Community Engagement Strategist
External Advisory Committee
Peter Buerhaus, PhD, RN, FAAN
Professor of Nursing
Director of the Center for Interdisciplinary Health Workforce Studies Montana State University
Amy Kilbourne, PhD, MPH
Professor of Psychiatry, University of Michigan Medical School
Director of VA Quality Enhancement Research Initiative (QUERI)
Phil Johnston, Pharm D
Vice Provost of Academic Affairs, Belmont University
Founding Dean, College of Pharmacy
Veronica Mallet, MD, MMM
Senior Vice President for Health Affairs
Dean, School of Medicine Meharry Medical College
Jonathon Perlin, MD, PhD, MSHA, MACP, FACMI
President, Clinical Services and Chief Medical Officer, Hospital Corporation of America